The role of extracellular vesicles in COVID-19 virus infection

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorHassanpour, Mehdi-
Autor(es): dc.creatorRezaie, Jafar-
Autor(es): dc.creatorNouri, Mohammad-
Autor(es): dc.creatorPanahi, Yunes-
Data de aceite: dc.date.accessioned2026-02-09T12:40:15Z-
Data de disponibilização: dc.date.available2026-02-09T12:40:15Z-
Data de envio: dc.date.issued2021-01-13-
Data de envio: dc.date.issued2021-01-13-
Data de envio: dc.date.issued2020-10-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/45999-
Fonte completa do material: dc.identifierhttps://www.sciencedirect.com/science/article/abs/pii/S1567134820302537-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1165949-
Descrição: dc.descriptionExtracellular vesicles releasing from various types of cells contribute to intercellular communication via delivering bio-molecules like nucleic acids, proteins, and lipids to recipient cells. Exosomes are 30–120 nm extracellular vesicles that participate in several pathological conditions. Virus-infected cells release exosomes that are implicated in infection through transferring viral components such as viral-derived miRNAs and proteins. As well, exosomes contain receptors for viruses that make recipient cells susceptible to virus entry. Since December 2019, SARS-CoV-2 (COVID-19) infection has become a worldwide urgent public health concern. There is currently no vaccine or specific antiviral treatment existing for COVID-19 virus infection. Hence, it is critical to find a safe and effective therapeutic tool to patients with severe COVID-19 virus infection. Extracellular vesicles may contribute to spread this virus as they transfer such receptors as CD9 and ACE2, which make recipient cells susceptible to virus docking. Upon entry, COVID-19 virus may be directed into the exosomal pathway, and its component is packaged into exosomes for secretion. Exosome-based strategies for the treatment of COVID-19 virus infection may include following items: inhibition of exosome biogenesis and uptake, exosome-therapy, exosome-based drug delivery system, and exosome-based vaccine. Mesenchymal stem cells can suppress nonproductive inflammation and improve/repair lung cells including endothelial and alveolar cells, which damaged by COVID-19 virus infection. Understanding molecular mechanisms behind extracellular vesicles related COVID-19 virus infection may provide us with an avenue to identify its entry, replication, spreading, and infection to overcome its adverse effects.-
Idioma: dc.languageen-
Publicador: dc.publisherElsevier-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceInfection, Genetics and Evolution-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectViral infection-
Palavras-chave: dc.subjectExtracellular vesicles-
Palavras-chave: dc.subjectExosomes-
Título: dc.titleThe role of extracellular vesicles in COVID-19 virus infection-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.